Gilead Sciences Commits to Electrifying Its Fleet
We’re pleased to have joined the Climate Group’s EV100 and to commit to electrifying our fleet of vehicles by 2030. As part of our ongoing efforts to protect the planet, we’ve also committed to using only 100% renewable energy by 2025.
“As a healthcare company, Gilead recognizes the clear connection between a healthy planet and the health of people. We envision a sustainable future and are committed to taking bold action to positively impace our communities. That’s why we’re proud to join the Climate Group’s EV100 and the RE100 initiatives – both are important steps to help battle climate change,” said Brett Pletcher, Executive Vice President, Corporate Affairs and General Counsel.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
